Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
- PMID: 1889465
- DOI: 10.1002/eji.1830210941
Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
Abstract
The major surface antigen of malaria sporozoites, the circumsporozoite protein, contains a region of tandem amino acid repeats, which in the case of the human malaria parasite Plasmodium falciparum, consist of four amino acids Asn-Ala-Asn-Pro (NANP) repeated up to about 40 times. This repetitive sequence has been considered as the basis for the development of subunit vaccines against P. falciparum malaria. We and others had previously shown that synthetic and recombinant NANP peptides were immunogenic only in H-2b mice. In the present report we show that, when mice with different H-2 haplotypes are immunized with the repetitive NANP sequence incorporated in a synthetic branching multiple antigen peptide (MAP), all except one of the mouse strains tested mounted an anti-peptide antibody response. Such a response does not appear to be due to the peculiar assembly of the NANP sequence. In fact, MAP containing repetitive sequences from circumsporozoite proteins of other malaria parasites did not overcome the genetic restriction of the immune response to the linear peptides. These data show that in the case of the P. falciparum NANP repeats, their immunogenicity can be dramatically changed and increased when these peptides are assembled as MAP. This unexpected finding may be of interest in the design of synthetic candidate malaria vaccines.
Similar articles
-
A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.Eur J Immunol. 1990 Jul;20(7):1619-22. doi: 10.1002/eji.1830200733. Eur J Immunol. 1990. PMID: 2201549
-
The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.J Immunol. 1986 Nov 1;137(9):2952-5. J Immunol. 1986. PMID: 3531341
-
Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.J Immunol. 1990 Oct 15;145(8):2691-6. J Immunol. 1990. PMID: 2212657
-
The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?Bull World Health Organ. 1990;68 Suppl(Suppl):66-73. Bull World Health Organ. 1990. PMID: 1709835 Free PMC article. Review.
-
Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.Bull World Health Organ. 1990;68 Suppl(Suppl):191-6. Bull World Health Organ. 1990. PMID: 2094587 Free PMC article. Review.
Cited by
-
Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.Immunology. 1996 Aug;88(4):630-5. doi: 10.1046/j.1365-2567.1996.d01-688.x. Immunology. 1996. PMID: 8881768 Free PMC article.
-
Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Infect Immun. 2002 Jul;70(7):3479-92. doi: 10.1128/IAI.70.7.3479-3492.2002. Infect Immun. 2002. PMID: 12065487 Free PMC article.
-
Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.Infect Immun. 1993 Jul;61(7):3064-7. doi: 10.1128/iai.61.7.3064-3067.1993. Infect Immun. 1993. PMID: 7685741 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources